I have been commenting that a market correction was likely in October and the marijuana licensed producers (LPs) were overvalued. This is why I had no new stock picks in October and only one in September. Patience is a tough discipline for investors but it most often pays off. I will now start adding some new picks to our list. Now is the time to buy as the Marijuana Index just bounced off the lowest point of the year (close enough) and has started a new rally. Major stock indexes have bounced off support and are in rallies as well.

With cannabis now officially legal in Canada, the floodgates have opened for any and all hybrids involving weed and there are a lot of incoming options if you aren't a smoker. Though one of the most popular impending hybrids has to be a marijuana-infused beer which promises to give you a high similar to the feeling you get while drunk, without the hangover in the morning. 

That claim alone has interested hundreds of Canadians in the company behind it, waiting for an official release date on the product that has been in the works since 2016. Thankfully, the brand is releasing one of their products in the very near future.

According to data compiled by Verified Market Intelligence, the global cannabis market was valued at USD 42.2 Billion in 2017 and is expected to reach USD 466.81 Billion by 2025. The market is also set to grow at a CAGR of 35.3% during the period. The strong growth rate for the market is attributable to the widespread legalization of medical and recreational cannabis. Many nations are adopting medical cannabis treatment for therapeutic reasons, while some are exploring opportunities within the recreational market. The North American region had dominated the cannabis market last year, controlling 95% of the market value, as the U.S. alone drove in 90% of the revenue. Micron Waste Technologies Inc. (OTC: MICWF), KushCo Holdings, Inc. (OTC: KSHB), Emerald Health Therapeutics Inc.

With the legalization of cannabis in Canada and nine U.S. states, the marijuana industry is wide open, but marketing the product still comes with its problems.

Canada has strict rules on branding—the packaging must be generic and informational with mandatory labels. There are even restrictions on colors.

More than half of New Brunswick’s legal cannabis stores are expected to stay closed Wednesday due to a pot shortage.

Disappointed customers approached one of the stores in Saint John Tuesday to be greeted by a ‘closed’ sign.

Some disgruntled customers saw the closures as growing pains, while others blamed poor planning.

“They don’t realize how many people have been buying under the table when it was illegal,” Keith Short told CTV Atlantic. “So if the government, if they keep the place stocked, they will make millions.” “I’m a little surprised that they didn’t think this far ahead,” Justin Maclean added.

“You’d think as a government corporation they would have put a little more thought into the opening month.”

When the curtain closes on 2018 in roughly eight weeks, it's likely to go down as the most monumental year on record for the legal cannabis industry. Though there have been major advances before -- including California becoming the first state to legalize medical marijuana in 1996 and Uruguay becoming the first country in the world to legalize recreational marijuana -- arguably nothing beats Canada's decision to legalize recreational marijuana in 2018.

As Canada's first licensed producer to receive a license for cannabis oil production without first receiving a cultivation license, MediPharm has turned the typical Canadian model - vertically integrated cultivator active in all aspects from seed to sale - on its head with its laser focus on oils and extracts, the highest value sector of the cannabis products market.

His net worth stands at close to $3.2 billion, according to Forbes. He became a legend at Goldman Sachs, helping build the firm's asset management business into a giant in the industry. He founded and ran one of the most successful hedge funds in the world. And now Leon Cooperman is investing his personal money in marijuana stocks.

CBD has long been a consistent performer of the overall cannabis market as industry leaders have enjoyed the flexibility of loopholes surrounding legalities, as well as a rising consumer sentiment toward alternative health options. CBD-infused products have allowed companies to expand into a variety of industries and continue to generate higher and higher revenues. The hemp-derived CBD market is projected to top $590 million in revenue, according to the Brightfield Group. The industry will continue growing as it matures, and is also expected to receive a boost if legislation removes CBD as a controlled substance in the near future. Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTC:MCOA), MariMed Inc.

Amid all the ruckus of 2018 an investing thesis has emerged that has taken Wall Street by storm: Marijuana stocks surged almost like bitcoin did in its heyday.

There was extreme exuberance stemming from the legalization of pot in Canada and marijuana stocks like Canopy Growth (NYSE:CGC) and Tilray(NASDAQ:TLRY) were rocket ships that seemed unstoppable. TLRY especially was a short stock nightmare as it became difficult to trade even through options. I was lucky enough to ride perfectly through long calls and short puts and it was still tough to fill my winning orders.